Purpose: To review the incidence of lamotrigine (LTG)-associated insomnia i
n an adult tertiary care epilepsy outpatient clinic.
Methods: The records of all patients who had received LTG were reviewed to
identify patients who had experienced insomnia after introduction of this d
rug. Patients were included if they had experienced a sleep disturbance of
sufficient severity to require a discontinuation of LTG or a dose reduction
.
Results: Among 109 patients exposed to LTG, seven (6.4%) had a sleep distur
bance of a severity to required a change in therapy. The descriptions of th
e sleep disturbance were similar among the patients, and the LTG-induced in
somnia appeared to be dose dependent. Unlike the few previous descriptions
of LTG-induced insomnia in the literature, no factors predisposing to this
adverse effect were identified.
Conclusions: The results of this retrospective review suggest an associatio
n between LTG and intolerable insomnia in a small proportion of patients. P
hysicians should inquire about sleep disturbances in patients treated with
LTG.